‘Amazing’ drugs deal for you, Donald, but what about the rest of us?
The US president is setting a dangerous precedent with deal to buy up vital Covid-19 drug supplies, say experts
The Donald Trump administration’s move to purchase virtually all stocks of remdesivir for the next three months has set a “dangerous precedent” and will undermine global efforts to tackle the pandemic, experts have warned.
The drug, produced by US-based Gilead Sciences, has been shown to cut recovery time for Covid-19 patients by four days and, at present, is one of only two that is proven to work against the virus.
However, the US has purchased more than 500,000 doses, which equates to all of Gilead’s projected production for July and 90% of the capacity for August and September...